Page 2 - Generics Act News Today

The U.S. House of Representatives is in recess while the U.S. Senate continues on with legislative business.

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and...

The House and Senate were both in session this week. The House Ways & Means Health Subcommittee met to discuss policies inhibiting innovation and patient access, and the House Energy &...

The U.S. House of Representatives and U.S. Senate are both in session for what is shaping up to be a busy healthcare week. The House Energy and Commerce Health Subcommittee scheduled...

This Week in Washington: Debt Limit fight continues; Disagreements arise during Senate HELP Committee mark-up of PBM and Generic Drug Competition Bills...

WASHINGTON, D.C. – U.S. Senator Tammy Baldwin (D-WI) introduced two bills to lower prescription drug costs and increase access to life-saving medications

 

Keith A Zullow and Jenny J Zhang examine upcoming US pharmaceutical regulation and how, if passed, it could impact European pharma/biopharma.

The Department of Health showcased a popular content creator's explainer video about generic medicine on its social media channels. The DOH used the video

The Big Molecule Watch is monitoring pending legislation in Congress that relates to biosimilars and biologics. In this post, we check in on the status of two currently pending bills...